Skip to content

Comparison of rectus muscle stiffness changes according to ropivacaine concentration during rectus sheath block in patients undergoing laparoscopic cholecystectomy

Association of Intraoperative and Postoperative Clinical Factors with Postoperative Outcomes in Patients Undergoing Laparoscopic Cholecystectomy: A Prospective Observational Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0011877
Enrollment
110
Registered
2026-04-20
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adult patients aged 19 to 74 years 2. Patients scheduled for laparoscopic cholecystectomy at Eunpyeong St. Mary’s Hospital 3. Patients undergoing a rectus sheath block for perioperative analgesia before surgery 4. Patients receiving a rectus sheath block with either 20 mL of 0.5% ropivacaine or 20 mL of 0.25% ropivacaine as part of routine clinical practice 5. Patients able to undergo shear wave elastographic assessment of rectus abdominis muscle stiffness before the block and 20 minutes after the block 6. Patients able to undergo stiffness measurement in both the resting state and during standardized active contraction using leg raising 7. Patients able to undergo sensory assessment and pain evaluation in the PACU and ward 8. Patients who voluntarily provide written informed consent after receiving a full explanation of the study purpose and procedures

Exclusion criteria

Exclusion criteria: 1. Patients who decline participation or are unable to provide written informed consent 2. Patients with known hypersensitivity or allergy to ropivacaine or other amide-type local anesthetics 3. Patients with local infection at the intended block site or clinically significant systemic infection 4. Patients considered unsuitable for the planned rectus sheath block by the attending anesthesiologist because of current bleeding risk, coagulopathy, or antithrombotic medication status 5. Patients with pre-existing abdominal wall neurologic abnormalities, significant structural abnormalities of the abdominal wall muscle or fascia, or other conditions that may interfere with interpretation of rectus muscle stiffness or sensory assessment 6. Patients who are unable to understand or cooperate with the study procedures, making serial shear wave elastography assessment in both the resting state and during leg raising unreliable 7. Patients in whom the rectus sheath block is performed with a concentration or volume different from the study protocol, or who receive additional abdominal wall block(s) before the primary assessment at 20 minutes 8. Patients for whom reliable measurement or interpretation of the primary outcomes is judged to be difficult by the investigators

Design outcomes

Primary

MeasureTime frame
Peak port-site pain score during ambulation on postoperative day 1

Secondary

MeasureTime frame
Change in rectus abdominis muscle stiffness in the resting state from baseline to 20 minutes after rectus sheath block;Change in the difference between active and resting rectus abdominis muscle stiffness from baseline to 20 minutes after rectus sheath block;Loss of cold sensation in the target abdominal wall area at 20 minutes after rectus sheath block;Peak port-site pain score during PACU stay;Cumulative rescue analgesic consumption during PACU stay;Cumulative analgesic consumption on postoperative day 1;Change in rectus abdominis muscle stiffness during standardized active contraction using leg raising from baseline to 20 minutes after rectus sheath block

Countries

Korea, Republic of

Contacts

Public ContactMinsuk Chae

The Catholic University of Korea, Eunpyeong St. Mary's Hospital

shscms@catholic.ac.kr+82-2-2030-4516

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: May 1, 2026